A former “Jeopardy!” champion admitted in a Brooklyn, New York, court Monday to posing as a child online to lure students ― including from the private school where he taught ― into sending sexually ...

WWE wrestlers just do not wish to be just the World Champions but also to be a Grand Slam Champion. Now, the question is what is WWE Grand Slam Champion? The WWE Grand Slam Championship, though not a ...

Now, the 2009 Masters champion readies for a return to Augusta National after being officially listed as one of the former champions set to take part. It is customary that former champions are ...

AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster autoimmune drug Rinvoq for the treatment of adults ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 - ...

Krystal Biotech said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Vyjuvek topical gene therapy for certain patients with the rare ...

(RTTNews) - AbbVie (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib ...

The positive opinion is based on results from the pivotal Phase 3 SELECT-GCA trial that evaluated the efficacy and safety of upadacitinib in adults with giant cell arteritis (GCA)1The primary ...

NORTH CHICAGO, Ill., Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...

If approved, Fabhalta ® will be the only medicine indicated to selectively target the underlying cause of C3G 1, an ultra-rare, progressive kidney disease with no currently approved treatments 2 ...